Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
45.58
+45.58 (+1012788.89%)
Official Closing Price
Updated: 7:00 PM EDT, May 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,986,405
Open
0.0045
Bid (Size)
45.52 (100)
Ask (Size)
45.65 (200)
Prev. Close
0.0045
Today's Range
45.15 - 45.89
52wk Range
35.12 - 81.44
Shares Outstanding
N/A
Dividend Yield
5.59%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
5 Best Growth Stocks for the Next 10 Years
↗
Today 7:45 EDT
These 5 long-term growth stocks could benefit from AI, cybersecurity, GLP-1 drugs, and fintech trends over the next decade
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors
↗
May 30, 2026
Eli Lilly is working on a new GLP-1 drug, and early results suggest it could be a big winner.
Via
The Motley Fool
Performance
YTD
-13.0%
-13.0%
1 Month
+8.0%
+8.0%
3 Month
+20.7%
+20.7%
6 Month
-5.9%
-5.9%
1 Year
-36.3%
-36.3%
More News
Read More
The Smartest Growth Stocks to Buy With $2,000 Right Now
↗
May 30, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Stock Split Watch: Is Eli Lilly Next?
↗
May 30, 2026
Via
The Motley Fool
Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now
↗
May 28, 2026
Via
The Motley Fool
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?
↗
May 28, 2026
Via
MarketBeat
Topics
Earnings
Novo Nordisk Is Beating Eli Lilly in the Obesity Pill Market. Should Lilly Investors Be Worried?
↗
May 27, 2026
Via
The Motley Fool
President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?
↗
May 27, 2026
Via
The Motley Fool
Topics
Government
Prediction: These 2 Obesity Drug Stocks Could Double in 2026
↗
May 26, 2026
Via
The Motley Fool
Don't Buy Viking Therapeutics Stock Until You Read This
↗
May 25, 2026
Via
The Motley Fool
Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro
↗
May 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know.
↗
May 25, 2026
Via
The Motley Fool
The Silver Lining of Last Week's Hims & Hers Earnings Miss
↗
May 21, 2026
Via
MarketBeat
Topics
Earnings
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
May 21, 2026
Via
FinancialNewsMedia
Topics
Government
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
May 21, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
Could Viking Therapeutics Be the Next Eli Lilly?
↗
May 21, 2026
Via
The Motley Fool
Best Weight Loss Drug Stocks to Buy in 2026
↗
May 20, 2026
Via
The Motley Fool
Topics
Intellectual Property
From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook
↗
May 20, 2026
Via
MarketBeat
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party
↗
May 18, 2026
Via
The Motley Fool
Eli Lilly Stock: Next Stop $2,000?
↗
May 18, 2026
Via
The Motley Fool
3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now
↗
May 18, 2026
Via
The Motley Fool
Topics
Intellectual Property
Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?
↗
May 17, 2026
Via
The Motley Fool
Buy, Sell, or Hold Novo Nordisk at $46?
↗
May 15, 2026
Via
The Motley Fool
2 Ways to Play the Big Pharma Patent Cliff
↗
May 15, 2026
Via
MarketBeat
Topics
ETFs
Intellectual Property
Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign?
↗
May 15, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 45.58
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 05/29/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.